fda glp-1 news november 2025 compounding semaglutide enforcement The FDA has released new guidance for providers prescribing GLP-1 Shortage = Over GLP-1s in 2026: What Brokers

The promising effects observed in vitro often require sophisticated formulations (e.g., with piperine, nanoparticles) to be partially translated in humans, raising questions about the efficacy of simple dietary intake or standard extracts (50)

Those Battling with Acne, Eczema, and Psoriasis: Address skin conditions with a holistic and effective approach

By addressing the various facets of obesity, including hormonal imbalances, metabolic issues, and lifestyle factors, we aim to help our patients not only lose weight but also maintain their progress long-term

This preserves and bolsters skin quality and resilience over time

The reason is how Epithalon is designed to work